101 related articles for article (PubMed ID: 10712572)
1. The effect of AVP-V2 receptor stimulation on local GFR in the rat kidney.
Roald AB; Tenstad O; Aukland K
Acta Physiol Scand; 2000 Feb; 168(2):351-9. PubMed ID: 10712572
[TBL] [Abstract][Full Text] [Related]
2. The effect of AVP-V receptor stimulation on local GFR in the rat kidney.
Roald AB; Tenstad O; Aukland K
Acta Physiol Scand; 2004 Oct; 182(2):197-204. PubMed ID: 15450116
[TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin antagonist improves renal function in a rat model of pneumoperitoneum.
Dolgor B; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Matsumoto T
J Surg Res; 1998 Oct; 79(2):109-14. PubMed ID: 9758724
[TBL] [Abstract][Full Text] [Related]
5. Effect of exogenous and endogenous angiotensin II on intrarenal distribution of glomerular filtration rate in rats.
Treeck B; Roald AB; Tenstad O; Aukland K
J Physiol; 2002 Jun; 541(Pt 3):1049-57. PubMed ID: 12068062
[TBL] [Abstract][Full Text] [Related]
6. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.
Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
J Endocrinol; 1994 Nov; 143(2):227-34. PubMed ID: 7829988
[TBL] [Abstract][Full Text] [Related]
7. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
[TBL] [Abstract][Full Text] [Related]
8. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.
Yamamura Y; Nakamura S; Itoh S; Hirano T; Onogawa T; Yamashita T; Yamada Y; Tsujimae K; Aoyama M; Kotosai K; Ogawa H; Yamashita H; Kondo K; Tominaga M; Tsujimoto G; Mori T
J Pharmacol Exp Ther; 1998 Dec; 287(3):860-7. PubMed ID: 9864265
[TBL] [Abstract][Full Text] [Related]
9. Renal hemodynamics in young and old spontaneously hypertensive rats during intrarenal infusion of arginine vasopressin.
Christiansen RE; Roald AB; Gjerstad C; Tenstad O; Iversen BM
Kidney Blood Press Res; 2001; 24(3):176-84. PubMed ID: 11528210
[TBL] [Abstract][Full Text] [Related]
10. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
Ledderhos C; Mattson DL; Skelton MM; Cowley AW
Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
[TBL] [Abstract][Full Text] [Related]
11. Effects of receptor blockade on metabolism and renal actions of vasopressin in conscious dogs.
Grove L; Christensen P; Bie P
Acta Physiol Scand; 1998 May; 163(1):93-101. PubMed ID: 9648627
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
[TBL] [Abstract][Full Text] [Related]
13. Chronic dDAVP infusion in rats decreases the expression of P2Y2 receptor in inner medulla and P2Y2 receptor-mediated PGE2 release by IMCD.
Sun R; Miller RL; Hemmert AC; Zhang P; Shi H; Nelson RD; Kishore BK
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F768-76. PubMed ID: 15914777
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
Albuquerque CA; Nijland MJ; Ross MG
J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
[TBL] [Abstract][Full Text] [Related]
15. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
Nakamura S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Yamamura Y; Mori T; Tominaga M
J Pharmacol Exp Ther; 2000 Dec; 295(3):1005-11. PubMed ID: 11082435
[TBL] [Abstract][Full Text] [Related]
16. Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
Brink HS; Derkx FH; Boomsma F; Schalekamp MA
Clin Nephrol; 1994 Aug; 42(2):95-101. PubMed ID: 7955585
[TBL] [Abstract][Full Text] [Related]
17. Effect of vasopressin V (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function.
Nakamura T; Sakamaki T; Kurashina T; Hoshino J; Sato K; Ono Z; Murata K
Life Sci; 1994; 55(4):PL67-72. PubMed ID: 8028441
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of vasopressin V1 and V2 receptors in the rabbit renal cortical collecting duct.
Yoshitomi K; Naruse M; Hanaoka K; Yamamura Y; Imai M; Kurokawa K
Kidney Int Suppl; 1996 Jun; 55():S177-82. PubMed ID: 8743549
[TBL] [Abstract][Full Text] [Related]
19. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
Furukawa Y; Takayama S; Ren LM; Sawaki S; Inoue Y; Chiba S
J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
[TBL] [Abstract][Full Text] [Related]
20. Vascular effects alter early-gestation fetal renal responses to vasopressin.
Ervin MG; Terry KA; Calvario GC; Castro R; Ross MG; Leake RD; Fisher DA
Am J Physiol; 1994 Mar; 266(3 Pt 2):R722-9. PubMed ID: 8160865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
